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ABSTRACT 
Cancer radiotherapy and modern synthetic medicine are critical for the treatment of cancer patients, but on the other hand they may have 
tremendous harmful side effect from the point of view of a weakened immune system. The focus of current research efforts in the industry and 
academia is not only to find affordable treatment methodologies but also to discover sources that mitigates or prevents the negative i mpact of 
these treatments on the patient’s immune system. This review will provide details of optimal methodology involving Invitro application of 
techniques such as phytochemical analysis, thin layer chromatography, cytogenetic analysis that were adopted to assess the efficacy of Alpinia 
Zerumbet extracts as a radioprotector. These methodologies provide a holistic evaluation technique for assessing any potential cytoprotective 
agent, especially if it’s from the herbal domain. As a case study, analytical and inferential results summary of the research conducted to assess 
radioprotective property of Alpinia Zerumbet, a herbal and readily available derivative, will be presented. The key findings from the research 
indicate that the Alpinia Zerumbet extract has potential to be an effective radioprotector, with minimal side effects as compared to synthetic 
chemical cytoprotective agents. 
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1 INTRODUCTION 
Cancer is known medically as a malignant neoplasm, is a 
broad group of various diseases, all involving unregulated 
cell growth. In cancer, cells divide and grow uncontrollably, 
forming malignant tumors, and invade nearby parts of the 
body. Global estimates for 2018, which cover 36 different 
cancers in 185 countries, report 18.1 million new cancer 
cases and approximately 9.6 million cancer-related deaths.[1] 
Rates are rising as more people live to an old age and as mass 
lifestyle changes occur in the developing world. There are 
many types of cancer treatment such as surgery, 
transplantation, gene, harmonal, chemo and radio therapy. 
Radiation therapy is one of the most common treatments for 
cancer. It is a local treatment which affects cancer cells only 
in the treated area. It is the medical use of ionizing radiation, 
generally as part of cancer treatment to control or kill 
cancerous cells using high-energy particles or waves, such as 
x-rays, gamma rays, electron beams, or protons, to destroy or 
damage cancer cells. It is also called radiotherapy, 
irradiation, or x-ray therapy. Radioprotective agents are 
commonly used to minimize the harmful side-effects of 
radiotherapy treatment. Most of the currently used 
radioprotective agents are derived synthetically and 
significantly increase the cost of cancer treatment.  The 
driver for the presented research is to discover the potential 
of Alpinia Zerumbet, a herbal source, which is affordable, 
safe and effective in minimizing the side of effects of 
commonly used cancer treatments of radiotherapy and also 
demonstrate the optimal evaluation technique that may be 
applied to evaluate the radioprotective properties of any 
chemical compound. 
1.1 Radiotherapy Mode of Action  
Radiotherapy is commonly applied to the cancerous tumor 
because of its ability to control cell growth. Ionizing radiation 
works by damaging the DNA of exposed tissue leading to 
cellular death. It is also common to combine radiation 
therapy with surgery, chemotherapy, hormone therapy, 
immunotherapy or some mixture of the four. Radiation 
involves the use of ionizing radiation to either cure or 
improve the symptoms of cancer. It is used in about half of all 
cases and the radiation can be from either internal sources in 
the form of brachytherapy or external sources. Radiation is 
typically used in addition to surgery and or chemotherapy 
and found effective for painful bone metastasis in about 70% 
of people. With the increasing technical power of 
radiotherapy to safely increase local tumor control for many 
solid tumors, it is an opportune time to rigorously explore 
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the potential benefits of combining radiotherapy with 
molecular targeted agents and immunotherapies to increase 
cancer survival outcomes [2]. 
The basic mechanism of action of radiotherapy is by 
damaging the DNA of cancerous cells. This DNA damage is 
caused by one of two types of energy, photon or charged 
particle. This damage is either direct or indirect ionization of 
the atoms which make up the DNA chain. Indirect ionization 
happens as a result of the ionization of water, forming free 
radicals, notably hydroxyl radicals, which then damage the 
DNA. 
Radiation therapy uses a special kind of high-energy beam to 
damage cancer cells. (Other types of energy beams include 
light and x-rays.) These high-energy beams, which are 
invisible to the human eye, damage a cell’s DNA. Cancer cells 
are less organized than healthy cells, it's harder for them to 
repair the damage done by radiation. Therefore, cancer cells 
are more easily destroyed by radiation, while healthy, 
normal cells are better able to repair themselves and survive 
the treatment. Radiation can come from a machine (external 
radiation). It can also come from an implant (a small 
container of radioactive material) placed directly into or 
near the tumor (internal radiation). Conformal radiotherapy 
and Intensity modulated radiotherapy (IMRT) are example of 
external source. Radioactive liquids, Radioactive implants 
(brachytherapy) are examples of internal radiation source. 
Radiotherapy is an important modality and provides benefit 
to cancer patients, particularly in cases where surgical 
intervention is advisable, for example, lung, head, and neck 
cancers. On the other hand, high dose of radiation results in 
severe side effect that often leads to discontinuation of 
treatment cycle [3]. In the work presented, multiple level of 
radiation exposures were used against which the 
cytoprotective evaluation was done. 
1.2 Radioprotectors 
Any drug that can provide therapeutic differentiations 
between cancerous and normal tissue and protect the latter 
would be of great utility in the clinic. The development of 
radio protectors is important from the point of view of 
improving the effectiveness of cancer treatment multifold 
and also for strategic reasons (planned and unplanned 
radiation exposure. 
A full range of research and development strategies is being 
employed currently in hunt for safe and effective 
radioprotections.  Restructuring or reformulating older 
protectants have proven efficacies but unwanted toxicities. 
Using nutraceuticals is only moderate protection but are 
essentially nontoxic. Using low dose combination of 
potentially toxic but effective agents, induce protection 
through different routes and fortifies radioprotective 
synergy [4]. The radio protector are agents or substances that 
provide protection against the toxic effect of ionizing 
radiation and reduce the toxicity, mutagenicity and other 
adverse biological effects of the ionizing radiations in the 
living beings. The aminothiols was the first group of 
identified compounds as potential radio protectors. The 
main types of radio protector substances are the Sulfhydryl-
groups compounds, amino acids, polyamines and other 
compounds, antioxidant and free radicals scavenger and 
lastly the phytochemicals compound [5]. 
In view of the significant side effects and associated high cost 
of these treatment, alternate radioprotectors which have 
similar efficacy and are more cost effective are needed to 
make cancer treatments more accessible and effective. 
Herbal derivatives is one such domain which may provide 
relevant alternatives for radioprotection. Alpinia Zerumbet 
was chosen for this evaluation. 
2. OBJECTIVE: ALPINIA ZERUMBET AS A HERBAL 
ALTERATIVE 
Bio-prospecting and natural products drug development for 
cancer treatment has become an important area. Most of the 
cancer radiotherapeutic agents are associated with toxicity 
towards normal cells and tissues. Optimal dosing of cancer 
radiotherapeutic agents is often limited because of severe 
non-myelosuppressive and myelo-suppressive toxicities. 
It is a continuing challenge to design therapy that is safer, 
effective and selective. Cytoprotective agents offer 
opportunities to reduce treatment related toxicity of 
anticancer therapy without diminution of efficacy. None of 
the available agents satisfy criteria for an ideal 
cytoprotection. This has stimulated research for discovering 
natural resources with immunomodulatory and 
cytoprotective activities. 
Alpinia Zerumbet also known as shell ginger, or Pink 
Porcelain-lily, is commonly used as a perennial decorative 
garden plant. The plant has globose red fruit. Native of 
South- East Asia. Alpinias grew from thick fleshy roots called 
“rhizome”, similar in appearance to the “ginger root”. The 
plant flowers on old growth and individual flowers are 
reminiscent of small seashells, which accounts for the 
common name “shell ginger” [6]. 
The pharmacological action of Alpinia Zerumbet Roxb. are 
alterative, analgesic, anthelmintic, anti-atrabilious, blood 
purifier, carminative, demulcent, deobastruent, diaphoretic, 
diuretic, emmenagogue, expectorant, febrifuge, purgative, 
resolvent, sedative, and anti-inflammatory. Alpinia Zerumbet 
has various medicinal properties as it is an anti-
inflammatory and analgesic. It contains rhizomes which are 
useful in rheumatism and catarrhal afflictions. In afflictions 
of gastrointestinal tract, the drugs can be used like other 
volatile oils. The rhizomes exhibit antiulcer activity.  The 
rhizomes contain dihydro 5, 6-dehydrokawain which has 
been reported to inhibit the aggregation of ATP release from 
rabbit platelets induced arachidonic acid and collagen [6].  
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Table1: Botanical Classification of Alpinia Zerumbet 
Kingdom Planteae –Plants 
Sub-kingdom Tracheobionta – Vascular plants 
Super-division Spermatophyta – Seed plants 
Division Magnoliophyta 
Class Lilliopsida – Monocotelydons 
Sub-class Zingiberadeaee 
Order Zingiberales 
Family Zingiberaceae-Ginger family 
Genus Alpinia Roxb - Alpinia (P) 
Species 
Alpinia Zerumbet (Pers) B.L.Burtt & 
R.M.Sm. –shell plant (P) 
 
 
Figure 3 : Botanical Classification of Alpinia Zerumbet 
 
Alpinia Zerumbet is a perennial plant widely distributed in 
subtropical and tropical regions. Consider to native north 
eastern India, Burma (myammar), indo-china and china and 
Japan. Besides it’s cultivated through Southeast Asia and in 
many other parts[7]. The species has also been naturalized in 
Brazil and is also found in some areas of central and South 
Florida. 
In terms of chemical constituents, Kava pyrone (DDK) is a 
medicinal compound has been detected in leaves, rhizomes, 
flowers and seeds of Alpinia Zerumbet [8]. It possesses 
several biological properties such as plant growth inhibition 
[18]., insecticidal activity and antifungal activity. In addition it 
has antiplatelet, antiulcergenic and antithrombotic effects. 
Some phenolic compounds have also been identified in 
Alpinia Zerumbet’s leaves [9]. In view of the above described 
properties the objective of the presented work is to evaluate 
the radiprotective properties of Alpinia Zerumbet as a herbal 
radioprotector. 
3. METHODOLOGY ADOPTED 
After processing of the plant leaves, extract was prepared 
using maceration/ percolation technique. The solubility of 
the extract was evaluated with multiple solvents such as 
DDW, 50% methanol, multiple DMSO concentrations: 10%, 
20%,30%, 40% and 50%. 50% methanol was found to be the 
most suitable solvent. 
Next, Phytochemical analysis of the extract was done 
wherein, tests were done to evaluate the presence of 
reducing sugars, proteins, sternoid and triterpenoid, cardiac 
glycosides, Anthraquinone Glycosides, Cynogeneic 
Glycosides, Coumarin Glycoside, falvonoids, alkaloids, gums, 
tannins and phenolic compounds. Further Thin layer 
chromatography analysis was done to determine the 
chemical constituents of the extract. 
Cytogenetic analysis was undertaken to finally evaluate the 
radioprotective properties of the extract against various 
levels of radiation (UV) exposure. Cytogenetic analyses are 
essential to the diagnosis and treatment of different forms of 
cancer, especially leukemia, cancers of the blood cell-forming 
system. The results of cytogenetic tests can help to confirm 
the diagnosis of a form of leukemia, and all the chromosomal 
abnormalities [10]. 
The cytogenetic analysis was done using cell culture. Below 
were the key aspects which were considered during the 
analysis. 
1. Pre-treating cells in a hypotonic solution, which swells 
them and spreads the chromosomes 
2. Arresting mitosis in metaphase by a solution of 
colchicine 
3. Squashing the preparation on the slide forcing the 
chromosomes into a single plane 
4. Cutting up a photomicrograph and arranging the result 
into an indisputable karyogram. 
Peripheral Blood Lymphocyte culture was done with 
heparinized blood and using RPMI-1640 media in aseptic 
condition. The test samples were exposed to different 
duration of radiation exposure along with 50% methanolic 
extract of Alpinia Zerumbet at different dosage were 
introduced. Drug control evaluation was set where the 
cultures were exposed only to various concentration of 50% 
methanolic extract of Alpinia Zerumbet, and only to radiation 
exposure for 0.5 and 1 hr. The cultured vials were incubated 
for 72 hours.  
The cultures were then harvested for micronucleus and 
apoptosis assay. 
The above described methodology may be utilized for any 
cytoprotective evaluation process. 
4. RESULTS AND DISCUSSION 
Prior to performing in vitro cytoprotective assay, 
phytochemicals analysis of the extract was performed and 
presence of different phytochemicals such as sugars, protein, 
steroid tri-terpiniod, cynogenetic glycosides, phenolic 
compound, anthraquinone, tannins flavonoids, and alkaloids 
was detected. 
radioprotective potentiality of the extract was studied on the 
basis of number of micronucleus containing cells (MN cells) 
and apoptotic cells (AP cells) found in the peripheral blood 
lymphocytes culture. 
To evaluate cytoprotective effect of the Alpinia Zerumbet, 5 
major groups for radiooprotection analysis were taken as 
part of the experiment these included 
To evaluate cytoprotective effect of the Alpinia zerumbet, 4 
major groups for radioprotection analysis were taken as part 
of the experiment these included 
1. NC- Normal control group (only Blood). 
2. RC- Radiotherapy control group treated with UV 
radiation with different exposure times. 
3. DC- Drug (Alpinia zerumbet extract) control group 
treated with 5 different concentrations of extract of 
Alpinia zerumbet to assess the genotoxicity of the drug. 
4. R&D- Drug and radiation therapy control group treated 
with different UV exposure times and drug 
administered either at the time of exposure or 24hrs 
after radiation exposure. 
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The number of micronucleus (MN) and apoptotic (AP) cells 
were observed per 100 cells and scored per group. Summary 
of the results for each group is presented below. 
1. In the case of normal control (NC) group, in which no 
treatment was given to the culture, no MN cells were 
found. 1% of the cells were seen to undergo apoptosis.  
2. The radiation group R1C, in which cells were exposed 
to UV radiation for half an hour, showed 12% of MN 
cells and 14% apoptotic cells. In the radiation group 
R2C, in which cells were exposed to UV radiation for 
one hr, we found 18% of MN cells and 20% of AP cells.  
3. In case of DC group, to see the genotoxic effect of 
extract, the culture was treated with various drug conc. 
i.e. 20%, 40%, 60%, 80%, 100%, minimal damage to 
cells was observed as 3-6% of the cells were found to 
contain MN cells, 60% drug conc. had maximum 
toxicity with 6% of MN cells, apoptosis was observed in 
9%, in case of 60% and 80% drug conc., 11% in 20% 
and 100% drug conc. and 10% in 40% drug conc. 
4. In case of R&D group, MN cells and AP cells were 
scored in the case of groups that were irradiated at the 
time of culture, with simultaneous treatment with 
various conc. of the drug. The groups exposed to half an 
hr UV radiation showed decrease in MN cells with 
respect to increase in drug conc.  MN cells decreased to 
8%, 6%, 6%, and 5% in culture treated with 20%, 40%, 
60%, and 80% respectively. At 100% drug conc., no MN 
cells were found. However, not much decrease in 
number of AP cells was observed 14%, 12%, and 15% 
AP cells were scored 20%, 40%, and 80% drug conc. 
respectively. It decreased up to 5% and 7% AP cells 
was seen in 60% and 100% drug conc. group.  
5. The cultures exposed to UV radiation for one hr, after 
drug treatment were observed for % of MN and AP 
cells. The drug concentrations were found to exhibit 
considerable protective effect as the % MN cells scored 
for conc. 20%, 40%, 60%, 80% and 100%, the 
frequency of MN cells was reduced to 8%, 6%, 8%, 3% 
and 5%, respectively when compared to the 18% found 
in radiation control group (R2C). However, not much 
decrease in frequency of AP cells was observed. 13% 
cells were found to have undergone apoptosis in 20% 
and 60% drug conc. treated groups, and 10%, 11%, and 
8% were found in 40%, 80%, and 100% drug conc. 
treated groups, respectively. 
MN and AP cells were also scored in the culture treated with 
drug at the time of culture and exposed to UV radiation after 
24 hrs for duration of half an hr and one hr. A large decrease 
in the number of MN cells was observed in case of drug 
pretreated culture irradiated after 24hrs with UV radiation 
for one hr duration. Except 20% drug conc., which had 4% 
MN cells, all other groups (40%, 60%, 80% and 100%) were 
found to possess 1-2% MN cells. However, decreased in AP 
cells were observed with respect to increasing drug conc. 9% 
AP cells were found in 20% drug conc. treated groups, 5% AP 
cells in case of 40% and 60% drug conc. groups, and 4% AP 
cells were found in respect to 80%, and 100% drug conc. 
Summary of the results are presented in Table 2 and 
statistical analysis figure 2,3,4,5: 
 
                                       
Figure 2         Figure 3 
 
 Figure 4          Figure 5 
Figure 2: Comparison of NC, MN and AP cells in control, radiation control (exposure ½ hr) and drug treated groups when drug 
is given as an adjuvant.. Figure 3: Comparison of NC, MN and AP cells in control, radiation control and drug treated group (1 hrs 
radiation) Figure 4 : Comparison of NC, MN and AP cells in control, radiation control (1/2 hr exposure after 24hrs of culture) 
and drug groups. Figure 5: Comparison of NC, MN and AP cells in radiation control and radiation drug control group (1 hrs 
radiation after 24 hrs of culture). 
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Table 2: Represents the Micronucleus, Apoptotic cells And Total cells in In-Vitro Lymphocyte culture treated with Radiation 
therapy and Aqueous Extracts of Alpinia Zerumbet leaf. 
S.No. Group Sub Group Total cell 
% of Normal 
cell 
% of Micronucleus 
cells 
% of Apoptic 
cells 
1 NC NC 100 99 0 1 
2 
RC 
R1C 100 74 12 14 
3 R2C 100 62 18 20 
4 
DC 
D1 100 84 3 11 
5 D2 100 86 4 10 
6 D3 100 85 6 9 
7 D4 100 87 5 9 
8 D5 100 85 4 11 
9 
RD 
D1a1 100 78 8 14 
10 D2a1 100 80 6 12 
11 D3a1 100 89 6 5 
12 D4a1 100 80 5 15 
13 D5a1 100 93 0 7 
14 D1a2 100 79 8 13 
15 D2a2 100 84 6 10 
16 D3a2 100 79 8 13 
17 D4a2 100 86 3 11 
18 D5a2 100 87 5 8 
19 D1b1 100 80 9 11 
20 D2b1 100 81 7 12 
21 D3b1 100 86 3 11 
22 D4b1 100 89 4 7 
23 D5b1 100 85 2 13 
24 D1b2 100 87 4 9 
25 D2b2 100 93 2 5 
26 D3b2 100 93 2 5 
27 D4b2 100 95 1 4 
28 D5b2 100 94 2 4 
 
Abbreviation: 
NC No Control 
RC Radiation Control 
DC Drug Control 
RD Radiation and Drug control 
R1 0.5hr radiation exposure 
R2 1 Hr Radiation exposure 
D1,D2,D3,D4,D5 10%,20%,30%,40%,50% drug conc. 
a1 Drug treatment at time  of exposure 
a2 Drug treatment 24hr after exposure 
 
5 CONCLUSIONS 
Radioprotective potential of alcoholic extract of Alpinia 
Zerumbet against various exposure levels of radiation was 
conducted. 
The effect of UV radiation on lymphocytes was studied. Also, 
radio protective effect of drug was studied to determine 
whether it has better protective activity as an adjuvant to 
radiation exposure or when it is administered prior to the 
exposure. 
The study shows that with increase in drug concentration, 
that radio protective effect exerted against UV radiation 
increases. When the drug was administered as an adjuvant, 
considerable decrease in the number of micronucleus 
containing cells was observed, for both the radiation 
exposure levels of half hour and one hour. This shows that 
the drug was effective in preventing chromosomal damage 
caused by radiation. However, it was not effective enough in 
prevention of the radiation induced apoptosis of cells. 
In the study, when the lymphocytes were pretreated with 
the drug 24 hrs before the radiation exposure, the drug was 
found to be effective in preventing chromosomal damage as 
well as induction of apoptosis. However, the protective effect 
was observed to be more in case of long exposure time, 
rather than the short half an hour exposure to UV radiation. 
This protective effect of the Alpinia Zerumbet leaf extract can 
be attributed to the presence of compound like flavonoids 
and phenolics, which are known to possess free radical 
scavenging activity. 
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